Search Results
Annette
I had been feeling unwell for quite a while. I would come home from work and go to bed right after dinner. I would sleep for hours and still be fatigued. When we had afternoon meetings, I would fall asleep. My husband and I kept thinking it was my very stressful job. I was on airplanes three times a week and would be traveling all over the country. I wasn’t eating or sleeping well. I finally decided to take early retirement. I still did not feel well even after being retired. I finally got to the point where I was so sick, I told my husband to take me to the emergency room.
Reid
I was diagnosed with chronic lymphocytic leukemia (CLL) in May 2022. It was a rough time with 10 blood transfusions, weeks in the hospital, and learning a new “normal”.
But that is not my story.
Lisa
I noticed some lymph nodes popped up on my neck so I went to the Dr. I didn't feel bad at all. My Dr ordered blood work and my white blood count was high. I was sent to The Cancer Center of Acadiana and more blood work, scans, ultrasound and bone biopsy was done. After all the results came in my white blood count was 99,000 and I had 75% leukemia cells in my bone marrow. I was diagnosed with CLL. 4 days later I was in the Infusion room at The Cancer Center of Acadiana. After 5 months of chemo going 2 days every month I am leukemia free.
Mike
I was diagnosed with chronic lymphocytic leukemia (CLL) in December 2004 at stage 0 which was revealed through a routine yearly physical.
Angela
I was diagnosed with chronic lymphocytic leukemia (CLL) in April 2009. I was so devastated. The first thing that got me through was a friend who had just won his battle with leukemia. I hadn't seen him in about a year, but he popped up all of a sudden that day and gave me hope.
A couple of months later, the oncologist and I agreed I would go into a wait and see period. He said it would likely be 6-10 years before I needed any treatment. I made it almost 6 years. I began treatment in March 2015.
What Is Blood Cancer?
Reviewed by Gwen Nichols, MD, EVP and Chief Medical Officer at The Leukemia & Lymphoma Society
Pan-heme CAR: Anti-CD38 CAR T cells for myeloid, lymphoid and plasma cell malignancies
Our SCOR team has a razor-sharp focus on an exciting new treatment modality for blood cancers: chimeric antigen receptor (CAR) T cells. T cells can be trained to target cancer cells by genetic modification. In fact, previous support from the Leukemia & Lymphoma Society allowed us to successfully develop CAR T cells targeted to CD19, a pan-B cell marker.
Daniel
I was diagnosed with chronic lymphocytic leukemia (CLL) in March 2010 at the age of 48. The cancer advanced rapidly and I was treated with a fludarabine/cyclophosphamide/rituximab (FCR) regimen at MD Anderson in Houston and locally in my hometown of Raleigh, NC between January and July of 2011. The treatment achieved a partial remission. However, in September of the same year I was diagnosed with a large diffuse b-cell lymphoma tumor in my lung.
Len
My son was rubbing my shoulders and noticed a lump on the side of my neck which freaked him out. He then told my wife about it and they demanded that I go have it checked. In November 2013, I was diagnosed with chronic lymphocytic leukemia (CLL).
I had my second round of treatment this past spring. The first one was rituxan alone and this last time was rituxan along with bendamustine for six months.
Alice
I was diagnosed with chronic lymphocytic leukemia (CLL). As soon as you learn that you have a form of cancer in your body, read a lot about it. Learn as much as you can about your cancer and how to talk to your doctor. It's up to you; it’s a mind situation. Don’t say, “Woe is me.” Say, “What should I do to take care of myself and enjoy life?” You are in charge, no one else can do it for you.
Dean
I was losing the battle with chronic lymphocytic leukemia (CLL) and lymphoma in August of 2013 when I ran across this quote from Albert Einstein, "There are only two ways to live your life. One is as though nothing is a miracle. The other is as though everything is a miracle." I decided to adopt this as my standard to live by. It gave me new insight and a passion for living that fueled my will to live.
Joseph
I came down with chronic lymphocytic leukemia (CLL) in 2006 which transformed into an aggressive form of non-Hodgkin B-cell lymphoma (NHL) in 2013. In 2015, I received an umbilical cord transplant at Penn Medicine Hospital in Philadelphia which was successful. This month, I celebrate nine years post-transplant.
Side Effects
Therapy for CLL sometimes produces side effects. Side effects from kinase inhibitor drugs and monoclonal antibody therapy are generally milder than side effects from chemotherapy.
For most patients, treatment side effects are temporary and go away once therapy ends. For other patients, side effects can be more severe, sometimes requiring hospitalization. Some patients never have side effects.
Howie
In January 2014 I got pneumonia for the third in under two years. The hematologists examined my blood and suspected CLL, since my white-blood count was so low. Then a bone-marrow biopsy confirmed this. This certainly explained my inability to fight infections. I skipped all the steps in the grieving process and went straight to acceptance: It is what it is.
Radiation Therapy
Radiation therapy uses X-rays or other high-energy rays to kill cancer cells. Radiation therapy is sometimes used to treat a person with CLL who has an enlarged (swollen) lymph node, spleen, or other organ that is blocking the function of a neighboring body part, such as the kidney or the throat.
Splenectomy
The spleen is an organ on the left side of the body, near the stomach. CLL cells can collect in the spleen, causing it to become enlarged. Sometimes, the spleen becomes so large that it presses on nearby organs, causing pain. Also, an enlarged spleen may lower a person’s blood cell counts to dangerous levels. An operation to remove the spleen is called a splenectomy. Splenectomy is helpful for select patients. The operation may reduce pain and help improve blood counts.
Michelle
I was originally diagnosed with Philadelphia chromosome + acute lymphoblastic leukemia (Ph+ ALL) in June 2017. My first month of treatment was a breeze, and I tolerated IV chemo well. Unfortunately, the rest of my two years of treatment wasn’t as smooth. I ended up in the pediatric intensive care unit for over a month. I was experiencing methotrexate toxicity and fighting for my life. Once I started recovering, I relearned how to walk, got my strength back, and continued fighting my fight. I was in remission by August 2017 and then finished treatment in June 2019!!
Treatment for Indolent NHL Subtypes
Indolent non-Hodgkin lymphoma (NHL) subtypes progress slowly. They make up about 40 percent of all NHL cases in the United States. Indolent subtypes include:
Charlene
Cancer. That is a word that is scary. So many of us have friends, family and co-workers that are impacted by some type of cancer, but you never think it will be you. The word conjures up fear. Fear of treatment, fear of death and fear of what will be expected of you to deal with and hopefully survive.
Gary
In 1999 I had a lump on my neck, and after strong urging from my wife and my mother, I finally went to my family doctor. My white blood cell counts were really high, and antibiotics didn't help. Eventually, a biopsy indicated chronic lymphocytic leukemia (CLL).
Chris
In 2008, my primary doctor noticed that my white blood cells were high (12,000 range) and referred me to a hematologist. The hematologist decided to "wait and see" for a while. From 2008 to 2018, we watched as my white cells slowly grew from 12,000 to 207,000. The oncologist then prescribed and 8-hour infusion of Rituxan. As I sat in the recliner chair with needle in arm, I got several violent reactions from the Rituxan and they pulled out the needle. The doctor told me that I needed a drug called Imbruvica (Ibutrinib). I was
Reduced-Intensity Allogeneic Stem Cell Transplantation
Reduced-intensity allogeneic stem cell transplantation (sometimes called mini-transplant or nonmyeloablative transplant), like a standard allogeneic stem cell transplantation, uses stem cells from a donor, but the conditioning treatment contains lower, less toxic doses of chemotherapy and radiation. This type of SCT may be an option for certain patients who are older or who are otherwise not healthy enough or strong enough to undergo standard allogeneic SCT.
Leukemia vs. lymphoma: What you need to know
Table of contents